S&P 500   3,136.28 (+0.01%)
DOW   27,906.86 (-0.01%)
QQQ   204.35 (+0.14%)
AAPL   269.31 (+0.90%)
FB   200.82 (-0.26%)
MSFT   151.48 (+0.08%)
GOOGL   1,343.94 (+0.07%)
AMZN   1,742.09 (-0.42%)
CGC   20.15 (-5.35%)
NVDA   214.78 (+1.23%)
MU   47.80 (+2.91%)
BABA   201.21 (+1.24%)
GE   11.02 (+0.27%)
TSLA   350.19 (+3.14%)
T   38.11 (+0.18%)
AMD   39.55 (+1.59%)
ACB   2.52 (-3.82%)
PRI   135.41 (+0.04%)
NFLX   296.13 (-2.11%)
BAC   33.53 (+0.06%)
GILD   66.91 (-0.03%)
DIS   146.15 (-0.04%)
S&P 500   3,136.28 (+0.01%)
DOW   27,906.86 (-0.01%)
QQQ   204.35 (+0.14%)
AAPL   269.31 (+0.90%)
FB   200.82 (-0.26%)
MSFT   151.48 (+0.08%)
GOOGL   1,343.94 (+0.07%)
AMZN   1,742.09 (-0.42%)
CGC   20.15 (-5.35%)
NVDA   214.78 (+1.23%)
MU   47.80 (+2.91%)
BABA   201.21 (+1.24%)
GE   11.02 (+0.27%)
TSLA   350.19 (+3.14%)
T   38.11 (+0.18%)
AMD   39.55 (+1.59%)
ACB   2.52 (-3.82%)
PRI   135.41 (+0.04%)
NFLX   296.13 (-2.11%)
BAC   33.53 (+0.06%)
GILD   66.91 (-0.03%)
DIS   146.15 (-0.04%)
S&P 500   3,136.28 (+0.01%)
DOW   27,906.86 (-0.01%)
QQQ   204.35 (+0.14%)
AAPL   269.31 (+0.90%)
FB   200.82 (-0.26%)
MSFT   151.48 (+0.08%)
GOOGL   1,343.94 (+0.07%)
AMZN   1,742.09 (-0.42%)
CGC   20.15 (-5.35%)
NVDA   214.78 (+1.23%)
MU   47.80 (+2.91%)
BABA   201.21 (+1.24%)
GE   11.02 (+0.27%)
TSLA   350.19 (+3.14%)
T   38.11 (+0.18%)
AMD   39.55 (+1.59%)
ACB   2.52 (-3.82%)
PRI   135.41 (+0.04%)
NFLX   296.13 (-2.11%)
BAC   33.53 (+0.06%)
GILD   66.91 (-0.03%)
DIS   146.15 (-0.04%)
S&P 500   3,136.28 (+0.01%)
DOW   27,906.86 (-0.01%)
QQQ   204.35 (+0.14%)
AAPL   269.31 (+0.90%)
FB   200.82 (-0.26%)
MSFT   151.48 (+0.08%)
GOOGL   1,343.94 (+0.07%)
AMZN   1,742.09 (-0.42%)
CGC   20.15 (-5.35%)
NVDA   214.78 (+1.23%)
MU   47.80 (+2.91%)
BABA   201.21 (+1.24%)
GE   11.02 (+0.27%)
TSLA   350.19 (+3.14%)
T   38.11 (+0.18%)
AMD   39.55 (+1.59%)
ACB   2.52 (-3.82%)
PRI   135.41 (+0.04%)
NFLX   296.13 (-2.11%)
BAC   33.53 (+0.06%)
GILD   66.91 (-0.03%)
DIS   146.15 (-0.04%)
Log in

NASDAQ:MGLN - Magellan Health Stock Price, Forecast & News

$78.38
+0.04 (+0.05 %)
(As of 12/10/2019 01:50 PM ET)
Today's Range
$77.69
Now: $78.38
$78.62
50-Day Range
$62.20
MA: $71.64
$80.52
52-Week Range
$53.26
Now: $78.38
$81.04
Volume3,062 shs
Average Volume182,356 shs
Market Capitalization$1.92 billion
P/E Ratio32.12
Dividend YieldN/A
Beta0.66
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. Read More…

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.31 billion
Cash Flow$7.84 per share
Book Value$52.99 per share

Profitability

Net Income$24.18 million

Miscellaneous

Employees10,500
Market Cap$1.92 billion
Next Earnings Date2/27/2020 (Estimated)
OptionableOptionable

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.


Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) announced its quarterly earnings data on Friday, November, 1st. The company reported $1.23 EPS for the quarter, missing the consensus estimate of $1.31 by $0.08. The company earned $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Magellan Health had a return on equity of 3.21% and a net margin of 0.10%. The business's revenue was down 1.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 EPS. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY19 earnings guidance on Friday, November, 1st. The company provided earnings per share guidance of $3.35-4.00 for the period, compared to the Thomson Reuters consensus estimate of $3.96. The company issued revenue guidance of $7-7.2 billion, compared to the consensus revenue estimate of $7.14 billion.

What price target have analysts set for MGLN?

2 equities research analysts have issued 12-month price objectives for Magellan Health's stock. Their forecasts range from $67.00 to $84.00. On average, they anticipate Magellan Health's share price to reach $75.50 in the next year. This suggests that the stock has a possible downside of 3.6%. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

Media stories about MGLN stock have been trending somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Magellan Health earned a coverage optimism score of 1.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Magellan Health.

Are investors shorting Magellan Health?

Magellan Health saw a drop in short interest during the month of November. As of November 15th, there was short interest totalling 561,400 shares, a drop of 10.4% from the October 31st total of 626,900 shares. Based on an average daily trading volume, of 180,000 shares, the days-to-cover ratio is currently 3.1 days. Approximately 2.3% of the company's shares are sold short. View Magellan Health's Current Options Chain.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Magellan Health investors own include Energy Transfer LP Unit (ET), Netflix (NFLX), Ford Motor (F), UnitedHealth Group (UNH), Starbucks (SBUX), Boston Scientific (BSX), CBL & Associates Properties (CBL), ConocoPhillips (COP), CVS Health (CVS) and D. R. Horton (DHI).

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State Street Corp (3.47%), Parametric Portfolio Associates LLC (1.17%), Man Group plc (1.06%), Millennium Management LLC (0.94%), Smith Graham & Co. Investment Advisors LP (0.74%) and Voya Investment Management LLC (0.60%). Company insiders that own Magellan Health stock include Barry M Smith, Daniel N Gregoire, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which major investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including Mackay Shields LLC, State Street Corp, Municipal Employees Retirement System of Michigan, Systematic Financial Management LP, Schafer Cullen Capital Management Inc, First Trust Advisors LP, Comerica Bank and Rhumbline Advisers. View Insider Buying and Selling for Magellan Health.

Which major investors are buying Magellan Health stock?

MGLN stock was acquired by a variety of institutional investors in the last quarter, including Man Group plc, Voya Investment Management LLC, Chicago Equity Partners LLC, SG Americas Securities LLC, State of New Jersey Common Pension Fund D, Millennium Management LLC, Assenagon Asset Management S.A. and Russell Investments Group Ltd.. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $78.28.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.92 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe.View Additional Information About Magellan Health.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com/.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  337 (Vote Outperform)
Underperform Votes:  351 (Vote Underperform)
Total Votes:  688
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel